56. Eli Lilly 2009 ($1,415 million)
In 2009, Eli Lilly agreed to pay a US$515 million criminal fine, a US$100 million forfeiture and a civil settlement of up to US$800 million after pleading guilty to marketing antipsychotic drug Zyprexa for uses which were not approved by the US Food and Drug Administration.
To read more
Subscribe to Global Investigations Review
Subscribe and start reading now
Global Investigations Review (GIR) is the hub for global coverage of corporate investigations and their aftermath. Keep up to date with significant developments in the corporate investigations world.